Evidence map›Paper›PMID 42168692›Full record

ArticlePrevention science : the official journal of the Society for Prevention Research2026

Assessment of Test Strips for Detection of Fentanyl in Powders.

Jessica L Armstrong, Rebekah E Wharton

Abstract read
PubMed Publisher
In one paragraph

Article in Prevention science : the official journal of the Society for Prevention Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jessica L ArmstrongOak Ridge Institute for Science and Education, Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA.
Rebekah E WhartonDivision of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA. flo2@cdc.gov.ORCID http://orcid.org/0000-0003-3027-3811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Testing drug powders before consumption is a harm reduction measure that could help prevent accidental overdoses. Fentanyl test strips (FTS) are used to test for fentanyl in powders, but comprehensive, comparative data assessing commercial test strips' performance is currently unavailable. To address this gap, we analyzed drug powders using FTS from three different vendors using the manufacturer's recommended testing procedures. Each FTS was assessed for sensitivity to fentanyl, cross-reactivity with fentanyl analogs, and selectivity by testing other relevant compounds. None of the FTS was as sensitive as claimed by the manufacturer nor could they detect all fentanyl analogs tested, which were selected based on their recent prevalence. The drugs responsible for the most false positives were stimulants, hallucinogens, synthetic opioids, and the cutting agent, diphenhydramine. Overall, testing of DanceSafe FTS resulted in the highest sensitivity for fentanyl, the highest selectivity when tested with other substances (fewest false positives), and moderate cross-reactivity with analogs. Testing of BTNX FTS resulted in the highest cross-reactivity with fentanyl analogs and moderate sensitivity for fentanyl. These results provide valuable information when selecting FTS for harm reduction as well as understanding the implications of each test's results. While no FTS tested performed as marketed, they still remain valuable as drug checking or screening tools to prevent drug overdose deaths.

Indexed as

FentanylReagent StripsHumansPowdersFentanylPowdersReagent StripsFentanylHarm reductionOverdose preventionTest strips

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.